An article from yesterday's New York Times details the coming challenges in deriving food from genetically modified organisms, particularly here in the US, where so far there aren't a lot of guidelines on the subject. Getting FDA to "spell out the rules of the game," the article says, could be the encouragement investors need to get active in this area -- while others contend that such guidelines would scare the public by having the GMO term associated with this food.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In an against-all-odds twist, a researcher studying exceeding rare FOXG1 mutations discovers her daughter has the syndrome.

An effort by Genomics Medicine Ireland is creating a database of diseases based on the genomics of people in Ireland. It now is looking into the possibility of including Scotland in its work.

In recent weeks, the direct-to-consumer genetics firm has rolled out a health hub where customers can share information concerning 18 common health conditions.

In PLOS this week, new genes associated with prostate cancer risk, genetic patterns in M. bovis, and more.